Work

Interleukin‐6 Inhibitor, Tocolizumab, for COVID‐19: evidence review of the clinical benefit and harm

Year: 2020

Type: article

Authors: A. Parrish, Andrew Gray, Tamara Kredo, Gary Maartens, Gary Reubenson, K. Cohen, R. de Waal, Marc Blockman, Jean Henri Nel, Helen Rees

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3045481649

FWCI:

Cites:

Cited by:

Related to: 10